Search alternatives:
cm decrease » _ decrease (Expand Search), nn decrease (Expand Search), c decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 cm » 5 mm (Expand Search), 5 c (Expand Search)
cm decrease » _ decrease (Expand Search), nn decrease (Expand Search), c decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 cm » 5 mm (Expand Search), 5 c (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Rho inactivation negatively affects biofilm formation in <i>B</i>. <i>subtilis</i>.
Published 2017“…RT-PCR analysis of rRNA (bottom section) was used as a control. Synthesis of cDNA was performed using 50 ng of total RNA as template (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1006909#sec019" target="_blank">Materials and methods</a>). …”
-
10
-
11
-
12
-
13
Kinetics and dose response of distinct changes to HDMEC barriers induced by TNF and IL-β.
Published 2015“…The corrected basal TEER for this experiment was 72.0 ± 1.5 Ω·cm<sup>2</sup>. n = 3,3. Representative of 10 (A), 12 (B), 3 (C, D and F) or 2 (E) independent experiments with similar results.…”
-
14
Proteolysis of VWF strings at the surface of HUVEC by recombinant ADAMTS13 variants under flow.
Published 2020“…<p>(A) HUVEC were perfused at 5 dyne/cm<sup>2</sup> shear stress with 1 mM histamine and 100 μl of GPIbα-beads in HBRS buffer. …”
-
15
-
16
-
17
-
18
-
19
-
20
Supplementary Material for: Identification of risk factors associated with metabolic dysfunction-associated steatotic liver disease in psoriatic patients
Published 2024“…Biochemical analysis revealed significantly higher C-peptide level in patients with MASLD compared with patients without MASLD (2.5 vs 1.6ng/ml, p=0.036). Moreover, MASLD patients were found to have a lower HDL level and higher glycemia, triglyceridemia, cholesterol and LDL levels than non-MASLD patients. 16.3% of patients with MASLD had fibrosis stage ranging from F2 to F4 based on liver stiffness measurement compared with only 10.6% of patients without MASLD. …”